Search
Subscribe Now
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Coins2Day 500
Coins2Day 500 U.S.
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Coins2Day 500
Coins2Day 500
Coins2Day 500 U.S.
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Pharmaceutical Industry
Pharmaceutical Industry
Page 36 of 100
Health
Moderna releases promising—but early—new coronavirus vaccine data
By
Sy Mukherjee
May 18, 2020
Magazine
The CEO who keeps animal pharm growing
By
Anne Sraders
May 16, 2020
Health
Antibody testing will be key—once we understand what the results mean
By
Sy Mukherjee
May 12, 2020
Newsletters
Gilead’s moral (and financial) COVID-19 conundrum
By
Sy Mukherjee
May 7, 2020
Health
Remdesivir is the first coronavirus treatment. So why is Gilead’s stock plunging?
By
Sy Mukherjee
May 1, 2020
Newsletters
The communities we forget during COVID-19
By
Sy Mukherjee
April 30, 2020
Health
Gilead’s remdesivir won’t be a COVID-19 miracle cure, but it’s still an important first step
By
Sy Mukherjee
April 30, 2020
Health
The coronavirus pandemic is impacting critical research into neuromuscular diseases
By
Sy Mukherjee
April 28, 2020
Tech
How a pharmacy delivery startup has capitalized on the coronavirus pandemic
By
Jeremy Kahn
April 21, 2020
Magazine
Big Pharma has the chance to come to the world’s rescue
By
Sy Mukherjee
April 20, 2020
Commentary
Prescription drug costs are spiraling, but price controls are the wrong solution
By
Karen Kerrigan
April 18, 2020
Newsletters
The key problem to solve in the quest for coronavirus treatments
By
Sy Mukherjee
April 9, 2020
Health
How the best workplaces in health care and biopharma are responding to COVID-19
By
Ed Frauenheim
April 9, 2020
Commentary
These pharmaceutical companies are the top inventors and innovators
By
IDEA Pharma
April 6, 2020
Health
Johnson & Johnson hopes to have its promising coronavirus vaccine approved by early 2021
By
Sy Mukherjee
March 30, 2020
Most Popular
Economy
'I just don't have a good feeling about this': Top economist Claudia Sahm says the economy quietly shifted and...
By
Eleanor Pringle
Future of Work
Ford CEO has 5,000 open mechanic jobs with up to 6-figure salaries from the shortage of manually skilled workers: 'We...
By
Marco Quiroz-Gutierrez
Success
In 2026, many employers are ditching merit-based pay bumps in favor of ‘peanut butter raises’
By
Emma Burleigh